Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
14 août 2024 16h05 HE
|
Cyclacel
Cyclacel provides Q2 2024 financial results and business update on fadraciclib precision medicine strategy
Federman & Sherwood Investigates CDK Global for Data Breach
23 juin 2024 11h51 HE
|
Federman & Sherwood
Federman & Sherwood Investigates CDK Global for Data Breach
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
22 déc. 2023 09h15 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Uber for Business Announces Integration with CDK Global, Driving Better Customer Experiences at Car Dealerships
24 janv. 2023 12h00 HE
|
Uber for Business
SAN FRANCISCO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Uber for Business, Uber’s global enterprise platform for managing business rides, meals, and deliveries, today announced an integration with CDK...
Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference
15 mars 2021 07h16 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference
10 févr. 2021 07h00 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
12 août 2020 16h05 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results
12 mai 2020 16h05 HE
|
Cyclacel
- Conference Call Scheduled May 12, 2020 at 4:30 p.m. ET - - Following Recent Financing Cash Runway to End of 2022 - BERKELEY HEIGHTS, N.J., May 12, 2020 (GLOBE NEWSWIRE) -- Cyclacel...
Cyclacel Announces Closing of $20 Million Public Offering
24 avr. 2020 16h05 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 24, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing...
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
21 avr. 2020 08h27 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 21, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing...